Cannabis Bioscience International Holdings, Inc. (CBIH) Gross Profit (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Gross Profit across 5 years of filings, most recently posting $8160.0 for Q1 2026.

• In Q1 2026, Gross Profit rose 282.75% year-over-year to $8160.0; the TTM figure through Feb 2026 stood at $97394.0 (down 67.37% YoY), while the FY2025 annual figure was $262916.0, up 29.36% from the prior year.
• Gross Profit came in at $8160.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $42766.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $170525.0 in Q3 2024 to a low of -$4465.0 in Q1 2025.
• Average Gross Profit over 5 years is $47583.6, with a median of $36588.5 recorded in 2025.
• Year-over-year, Gross Profit slumped 118.15% in 2025 and soared 282.75% in 2026.
• Over 5 years, Gross Profit stood at $75491.0 in 2022, then plunged by 35.55% to $48656.0 in 2023, then soared by 36.56% to $66445.0 in 2024, then slumped by 35.64% to $42766.0 in 2025, then slumped by 80.92% to $8160.0 in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $8160.0 in Q1 2026, $42766.0 in Q4 2025, and $16057.0 in Q3 2025.